JPMorgan Chase & Co’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $447 | Sell |
1,129
-148
| -12% | -$59 | ﹤0.01% | 5818 |
|
|
2025
Q1 | $443 | Buy |
1,277
+148
| +13% | +$51 | ﹤0.01% | 5839 |
|
|
2024
Q4 | $667 | Hold |
1,129
| – | – | ﹤0.01% | 5719 |
|
|
2024
Q3 | $1.99K | Sell |
1,129
-7,211
| -86% | -$12.7K | ﹤0.01% | 5557 |
|
|
2024
Q2 | $11.4K | Sell |
8,340
-22,223
| -73% | -$30.4K | ﹤0.01% | 5227 |
|
|
2024
Q1 | $105K | Sell |
30,563
-8,417
| -22% | -$29K | ﹤0.01% | 4712 |
|
|
2023
Q4 | $95.9K | Sell |
38,980
-6,559
| -14% | -$16.1K | ﹤0.01% | 4783 |
|
|
2023
Q3 | $77.4K | Buy |
45,539
+173
| +0.4% | +$294 | ﹤0.01% | 4750 |
|
|
2023
Q2 | $136K | Buy |
45,366
+35,292
| +350% | +$106K | ﹤0.01% | 4488 |
|
|
2023
Q1 | $27K | Sell |
10,074
-155,719
| -94% | -$417K | ﹤0.01% | 5070 |
|
|
2022
Q4 | $1.37M | Sell |
165,793
-112,418
| -40% | -$928K | ﹤0.01% | 3200 |
|
|
2022
Q3 | $2.14M | Buy |
278,211
+3,380
| +1% | +$26K | ﹤0.01% | 2862 |
|
|
2022
Q2 | $783K | Buy |
274,831
+258,597
| +1,593% | +$737K | ﹤0.01% | 3619 |
|
|
2022
Q1 | $81K | Buy |
16,234
+1,247
| +8% | +$6.22K | ﹤0.01% | 4829 |
|
|
2021
Q4 | $295K | Sell |
14,987
-11,509
| -43% | -$227K | ﹤0.01% | 4342 |
|
|
2021
Q3 | $780K | Buy |
26,496
+18,114
| +216% | +$533K | ﹤0.01% | 3742 |
|
|
2021
Q2 | $356K | Sell |
8,382
-71,724
| -90% | -$3.05M | ﹤0.01% | 4187 |
|
|
2021
Q1 | $4.07M | Buy |
80,106
+79,018
| +7,263% | +$4.02M | ﹤0.01% | 2787 |
|
|
2020
Q4 | $37K | Buy |
+1,088
| New | +$37K | ﹤0.01% | 4502 |
|